We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Fluorescence-Based Method Detects Misfolded Proteins in Cells

By LabMedica International staff writers
Posted on 25 Feb 2019
Print article
Image: The new AggTag method allows researchers to see the previously undetectable but potentially disease-causing intermediate forms of proteins as they misfold. The method uses fluorescence to simultaneously detect two different proteins (red, green) within the cell (blue) (Photo courtesy of the Zhang Laboratory, Pennsylvania State University).
Image: The new AggTag method allows researchers to see the previously undetectable but potentially disease-causing intermediate forms of proteins as they misfold. The method uses fluorescence to simultaneously detect two different proteins (red, green) within the cell (blue) (Photo courtesy of the Zhang Laboratory, Pennsylvania State University).
A new fluorescence-based method is expected to boost studies on toxic insoluble proteins by detecting aggregation of two proteins in live cells simultaneously.

Protein aggregation involves the assembly of partially misfolded proteins into oligomeric and higher‐order structures that have been associated with several neurodegenerative diseases. However, numerous questions regarding protein aggregation remain unanswered due to the lack of available tools to visualize these species in living cells.

In this regard, investigators at Pennsylvania State University (University Park, USA) recently (published in the June 8, 2018, online edition of the Journal of the American Chemical Society) developed a fluorogenic method named Aggregation Tag (AggTag), and presented the AggTag probe P1 based on a Halo‐tag ligand to report on the aggregation of a protein of interest in live cells. Halo-tag is a self-labeling protein tag. It is a 297-residue peptide derived from a bacterial enzyme, designed to covalently bind to a synthetic ligand of choice and fuse to a protein of interest. The Halo-tag is composed of two covalently bound segments including a haloalkane dehalogenase and a synthetic ligand of choice. These synthetic ligands consist of a reactive chloroalkane linker bound to a functional group such as biotin or a fluorescent dye, which can be used in the visualization of either living or chemically fixed cells.

Since the Halo‐tag based AggTag method only detected the aggregation of one specific protein of interest at a time, the investigators expanded the AggTag method by using SNAP‐tag technology to enable fluorogenic and biorthogonal detection of the aggregation of two different proteins of interest simultaneously in live cells. A new AggTag probe P2 based on a SNAP‐tag ligand bearing a green fluorescent label was synthesized for this purpose. SNAP-tag is a self-labeling protein tag commercially available in various expression vectors. It is a 182 residues polypeptide that can be fused to any protein of interest and further specifically and covalently tagged with a suitable ligand, such as a fluorescent dye.

The investigators reported in the January 4, 2019, online edition of the journal ChemBioChem that by using confocal imaging and chemical crosslinking experiments, they were able to confirm that P2 could also report on both soluble oligomers and insoluble aggregates of a protein of interest fused with SNAP‐tag in live cells. In addition, they showed that the orthogonal fluorescence of P1 and P2 allowed for simultaneous visualization of two different pathogenic protein aggregates in the same cells.

"In order to function properly, proteins fold into very precise structures, but environmental stress or pathogenic mutations can cause proteins to misfold and aggregate," said senior author Dr. Xin Zhang, assistant professor of chemistry, biochemistry, and molecular biology at Pennsylvania State University. "Protein aggregation is a multi-step process, and it is believed that the intermediate form, which previous imaging techniques could not detect, is responsible for a number of diseases, including Alzheimer's, Parkinson's, Type II diabetes, and cystic fibrosis. We developed the Aggregation Tag method--AggTag--to see these previously undetectable intermediates--soluble oligomers--as well the final aggregates in live cells."

"We plan to continue developing this method so that we can signal the transition of oligomers into insoluble aggregates using a color change," said Dr. Zhang. "This method provides a new toolbox to study protein aggregation, which is currently a highly studied topic among scientists. Hopefully this will allow us to better understand the entire process of protein aggregation and the role of each of these forms in the progression of neurodegenerative and other diseases."

Related Links:
Pennsylvania State University

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.